# Delta Pharma Inc. – FDA Inspection, Aug 15, 2024

Source: https://www.keypedia.com/records/fda_inspections/delta-pharma-inc/3f728926-0d47-45d7-b1db-e2d68a729c17
Source feed: FDA_Inspections

> FDA inspection 1246599 of Delta Pharma Inc., August 15, 2024. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1246599
- Company Name: Delta Pharma Inc.
- Inspection Date: 2024-08-15
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1073955 - 2018-11-16](https://www.keypedia.com/records/fda_inspections/delta-pharma-inc/f925a256-9a68-4f21-a554-d8060d08cfbf)
- FDA Inspection 948746 - 2015-10-30
- FDA Inspection 771028 - 2012-02-09

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/matthew-b-casale/e78481c6-5fbd-4723-a79c-167176395af8)

Company: https://www.keypedia.com/companies/delta-pharma-inc/3ca0728b-6842-4cba-af5d-d1d28e9d24e7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c